Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Oaktree Capital urges UK’s Indivior to refresh board
    Finance

    Oaktree Capital urges UK’s Indivior to refresh board

    Published by Uma Rajagopal

    Posted on November 9, 2024

    2 min read

    Last updated: January 28, 2026

    Oaktree Capital Management advocates for a board refresh at Indivior following significant profit warnings. This image highlights the financial implications in the drug industry.
    Oaktree Capital Management urges Indivior to refresh its board amid profit warnings - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:Appointmentmanagementcorporate governancefinancial servicesinvestment

    (Reuters) –Investment fund Oaktree Capital Management has urged British drugmaker Indivior to cooperate with the fund in refreshing its board of directors, it said in a letter dated Nov. 6 and published in a filing on Thursday.

    The request from the fund, which became the company’s second largest shareholder in July, comes weeks after Indivior issued its second profit and revenue warnings in a span of three months, citing lower than expected sales from its opioid addiction treatment.

    The company’s opioid addiction treatment Sublocade has been losing market share due to the rapid adoption of Brixadi, a competing drug developed by Swedish pharmaceutical firm Camurus.

    The company essentially disregarded Brixadi’s entrance into the market by failing to take basic steps to protect Sublocade’s competitive position,” Oaktree said in the letter.

    Shares in the British drugmaker have slumped about 40% so far this year.

    Oaktree, which specialises in providing rescue funding to struggling firms, had a 7.37% stake in the drugmaker, according to data compiled by LSEG.

    Investment manager Two Seas Capital is the top shareholder with a 10.25% ownership.

    Indivor, in a statement, said it has actively engaged with Oaktree in recent weeks and remains “open-minded” to all proposals.

    In July, the drugmaker had taken a $86 million hit in a settlement over its alleged role in spreading opioid addiction across the United States.

    (Reporting by Yamini Kalia and Aby Jose Koilparambil in Bengaluru; Editing by Mrigank Dhaniwala and Alan Barona)

    Frequently Asked Questions about Oaktree Capital urges UK’s Indivior to refresh board

    1What is corporate governance?

    Corporate governance refers to the systems, principles, and processes by which a company is directed and controlled. It encompasses the relationships among the company's management, board of directors, shareholders, and other stakeholders.

    2What is an investment fund?

    An investment fund is a pool of money collected from multiple investors to invest in various financial securities, such as stocks, bonds, or real estate, managed by professionals to achieve specific financial goals.

    3What is a board of directors?

    A board of directors is a group of individuals elected to represent shareholders and oversee the activities of a company. They are responsible for making key decisions and ensuring the company's long-term success.

    4What is a profit warning?

    A profit warning is a statement issued by a company indicating that its earnings will fall below market expectations. This can impact the company's stock price and investor confidence.

    5What is market share?

    Market share is the percentage of an industry's sales that a particular company controls. It is used to assess a company's competitiveness and performance within its market.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostChina unveils $1.4 trln local debt package but no direct stimulus
    Next Finance PostPartners Group explores sale of stake in Britain’s ISP schools, sources say